TI
IBRX icon

Tidal Investments’s ImmunityBio IBRX Stock Holding History

Tidal Investments’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
+252,048
New +$1.91M ﹤0.01% 1308
2024
Q3 		– Sell
-64,255
Closed -$406K – 1898
2024
Q2 		$406K Sell
64,255
-28,584
-31% -$188K 0.01% 1404
2024
Q1 		$499K Buy
+92,839
New +$420K 0.01% 1201
2022
Q2 		– Sell
-11,219
Closed -$63K – 1139
2022
Q1 		$63K Buy
+11,219
New +$68.8K ﹤0.01% 1082

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidal Investments's IBRX Position: Q2 2026 in Review

Tidal Investments opened a new position in ImmunityBio (IBRX) in Q2 2026: 252,048 shares worth $2.21M. The stake represents ﹤0.01% of the portfolio and ranks #1308 among its holdings. This is a return to the name: Tidal Investments previously reported a position in IBRX as recently as Q2 2024.

Tidal Investments first reported a position in IBRX in Q1 2022 and has held it in 4 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Tidal Investments held 252,048 shares of ImmunityBio worth $2.21M as of Q2 2026.
  • ImmunityBio was a new Tidal Investments position in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1308 holding.
  • Tidal Investments first reported a position in ImmunityBio in Q1 2022 and has held it in 4 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.